Accelerate to discover
Related topics
IncuCyte webinar: high throughput approach to developing T- Cell immunotherapies
Jun 17, 2019
Immunotherapy for cancers involves artificially prompting the immune system to treat cancer. Many cancer cells have...
IncuCyte virtual event: Dimension of time - from culture to assay
Jun 5, 2019
This event offers an overview of how live-cell analysis enables real-time analysis for the full workflow of the cells....
Webinar recording: Detecting cancer-associated structural variants using Bionano optical maps
May 15, 2019
Bionano’s genome mapping technology directly observes long molecules from 150,000 bp to megabase pair lengths to...
IncuCyte webinar recording: Human Neurons in vitro, next-gen models for neurological disease
Apr 23, 2019
The ability to generate and manipulate human neurons in vitro is an exciting advance that enables the validation,...
Rapid, Quantitative CEST Imaging with MRI Fingerprinting
Apr 16, 2019
With applications spanning almost any disease area, from cancer, stroke, through to cardiac metabolism disorders, this...
Monitoring cancer treatments with immuno-PET webinar
Mar 8, 2019
In this webinar, Dr Gabriela Kramer-Marek, Team Leader in Preclinical Molecular Imaging The Institute of Cancer...
Spectral data analysis webinar recording - Cytek flow cytometer and De Novo Software
Jan 17, 2019
Cytek Biosciences and De Novo Software are proud to announce a collaboration that allows you to work with your spectral...
IncuCyte webinar recording: CAR T-cell therapy, frontiers in cancer Immunotherapy
Jan 11, 2019
The success of immune checkpoint blockade adds new therapeutic category to Cancers are the most heterogenous group of...
Jun 13, 2016
Friday, June 17th, 2016, 5 pm CEST.
High content functional assays that can monitor parameters such as membrane integrity, cytokine release, and more, are critical to understanding target cell response to immunotherapies and allow for rational design of improved therapies.
This webinar will highlight:
- Challenges posed by current methods to screen the efficacy of immunotherapies.
- The need for high content robust tools to evaluate current immunotherapeutic approaches such as adoptive cell therapy, checkpoint blockade etc.
- The ability of the iQue Screener platform to acquire single-cell data on multiple biological readouts in a quantitative, high-throughput fashion and better understand functional efficacy of immuno-oncology therapies.
Get more info
Brand profile
IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.
More info at:
www.intellicyt.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
